(Total Views: 220)
Posted On: 02/15/2022 1:41:05 PM
Post# of 144650
$TGTX News Article - TG Therapeutics Announces Data Presentations from the ULTIMATE I & II Phase 3 Trials of Ublituximab in Multiple Sclerosis to be Presented at the Americas Committee for Treatment and Research in Multiple Sclerosis Annual Forum https://marketwirenews.com/news-releases/tg-t...27887.html
(0)
(0)
My Twitter: WhyteStocks
Scroll down for more posts ▼
